Medtronic Announces FDA Clearance and First Patient Procedure with the Achieve Mapping Catheter

Medtronic, Inc. MDT today announced the U.S. Food and Drug Administration approval for use, and the first patient procedure using the Achieve™ Mapping Catheter, an intra-cardiac electrophysiology diagnostic catheter that can be used to assess pulmonary vein isolation when treating paroxysmal atrial fibrillation. The new catheter technology is approved for use with Medtronic's Arctic Front® Cardiac CryoAblation Catheter System to provide a more straightforward treatment approach by combining pulmonary vein diagnostic and ablation capabilities in a single system. The first patient procedure in the United States using the new Achieve Mapping Catheter was performed last week by Robert Kowal, M.D., Ph.D., an electrophysiologist at the Baylor Heart & Vascular Hospital in Dallas.